RA Ross - British journal of pharmacology, 2003 - Wiley Online Library
A large body of evidence now exists to substantiate that the endocannabinoid, anandamide,
activates TRPV1 receptors. It is a low intrinsic efficacy TRPV1 agonist that behaves as a …